Spectral MD Holdings Ltd (AIM:SMD) said its Regulation S restrictions, which prevent American investors from buying its stock, have been lifted.
Removing the designation opens up a new and potentially significant market for shares in the med-tech company, which may ultimately enhance liquidity.
Spectral MD is the creator of DeepView, an artificial intelligence-driven imaging device that can tell with 92% accuracy whether a burn will heal naturally or require surgery.
This saves time and money – and for the patient, it can prevent a protracted and painful convalescence.
The wait-and-see approach deployed by doctors can take up to three weeks; DeepView works in seconds.